ImmunityBio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IBRX?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	98,535,253	9.58%
Institutions	175,023,859	17%
General Public	204,429,960	19.9%
VC/PE Firms	254,388,436	24.7%
Individual Insiders	295,733,948	28.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.5%.

Top Shareholders

Top 25 shareholders own 77.22% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
28.3%	Patrick Soon-Shiong	291,407,566	US$2.6b	0.05%	no data
24.7%	California Capital Equity, LLC	254,388,436	US$2.3b	0%	99.79%
9.58%	NantWorks, LLC	98,535,253	US$882.9m	0%	no data
3.19%	The Vanguard Group, Inc.	32,777,257	US$293.7m	18.5%	no data
2.49%	BlackRock, Inc.	25,601,219	US$229.4m	29.2%	no data
1.6%	State Street Global Advisors, Inc.	16,455,703	US$147.4m	45.4%	no data
1.38%	Jane Street Group, LLC	14,224,224	US$127.4m	10.8%	0.17%
0.77%	Geode Capital Management, LLC	7,920,178	US$71.0m	15%	no data
0.55%	The Goldman Sachs Group, Inc.	5,690,446	US$51.0m	875%	0.02%
0.55%	Chan Soon-Shiong Family Foundation	5,618,326	US$50.3m	0%	100.0%
0.49%	Morgan Stanley	5,057,451	US$45.3m	51.5%	no data
0.46%	Two Sigma Investments, LP	4,717,843	US$42.3m	80.9%	0.08%
0.36%	Susquehanna International Group, LLP	3,654,499	US$32.7m	20.4%	0.04%
0.34%	Woodline Partners LP	3,446,540	US$30.9m	-34.9%	0.13%
0.29%	AlphaCore Capital LLC	3,000,544	US$26.9m	0.4%	0.66%
0.28%	Barry Simon	2,850,821	US$25.5m	-12.1%	no data
0.24%	Charles Schwab Investment Management, Inc.	2,501,666	US$22.4m	8.79%	no data
0.24%	UBS Asset Management AG	2,456,783	US$22.0m	16.8%	no data
0.24%	Barclays PLC	2,443,951	US$21.9m	164%	0.01%
0.23%	Tang Capital Management, LLC	2,333,333	US$20.9m	0%	1.12%
0.22%	Bank of America Corporation	2,312,552	US$20.7m	43.2%	0.01%
0.22%	Northern Trust Global Investments	2,230,112	US$20.0m	11.3%	no data
0.15%	Voleon Capital Management LP	1,514,586	US$13.6m	9,220%	0.35%
0.15%	Squarepoint OPS LLC	1,494,713	US$13.4m	47.5%	0.03%
0.13%	SEB Investment Management AB	1,324,871	US$11.9m	0%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/06 12:28
End of Day Share Price	2026/03/06 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ImmunityBio, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Justin Zelin	BTIG
Suranjit Mukherjee	BTIG
Jason Kolbert	D. Boral Capital LLC.